NCT07725055Not yet recruiting
AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
Primary objective: \- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope. Secondary objectives: * To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- First submitted
- 21 Jul 2026
- Start date
- Sept 2026
- Primary completion date
- Sept 2026
- Lead sponsor
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- Diseases
- Glaucoma
- NCT number
- NCT07725055
What you commit to
- Study type: Interventional
- Planned participants: 260
- From Sept 2026 to the primary completion date, Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects taking medications or suffering from a medical condition that could interfere with the evaluations planned under the protocol;
- Participants allergic to tropicamide in cases where pupil dilation is required. ☞ Wearing glasses or contact lenses to correct a refractive error is not considered an exclusion criterion.
Other
- For all subjects:
- Inability to remain motionless on a standard ophthalmic chin rest. RETION\_Protocol\_v2.0 dated June 10, 2026\_IDRCB: 2026-A00324-47 Page 10 of 44
Who the study is looking for
- Patients:
- 100 subjects aged 10 to 79 years with a condition that may affect the inner retina (e.g., glaucoma, optic neuropathy, etc.)
- 100 subjects aged 10 to 80 years with a condition that may affect the outer retina (e.g., AMD, retinitis pigmentosa, etc.)
- Male or female
- Covered by health insurance
- Healthy volunteers:
- 30 subjects aged over 50 and under 80
- 30 subjects aged over 18 and under 50
- Male or female
- Healthy subjects with no known condition that directly or indirectly affects the structure of the eye
- Covered by health insurance
Age in the registry: 10 years to 79 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.